Brain Interstitial Nociceptin/Orphanin FQ Levels are Elevated in Parkinson's Disease-Reference-Cited by-同舟云学术

Brain Interstitial Nociceptin/Orphanin FQ Levels are Elevated in Parkinson's Disease

Published:2010-06-29 Issue:11 Volume:25 Page:1723-1732
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov. Disord.

Author:

Marti Matteo,Sarubbo Silvio,Latini Francesco,Cavallo Michele,Eleopra Roberto,Biguzzi Sara,Lettieri Christian,Conti Carlo,Simonato Michele,Zucchini Silvia,Quatrale Rocco,Sensi Mariachiara,Candeletti Sanzio,Romualdi Patrizia,Morari Michele

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Reference48 articles.

1. The molecular and behavioral pharmacology of the orphanin FQ/Nociceptin peptide and receptor family;Mogil;Pharmacol Rev,2001

2. The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential;Lambert;Nat Rev Drug Discov,2008

3. Blockade of nociceptin/orphanin FQ transmission in rat substantia nigra reverses haloperidol-induced akinesia and normalizes nigral glutamate release;Marti;J Neurochem,2004

4. Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease;Marti;J Neurosci,2005

5. Endogenous nociceptin/orphanin FQ (N/OFQ) contributes to haloperidol-induced changes of nigral amino acid transmission and parkinsonism: a combined microdialysis and behavioral study in naïve and nociceptin/orphanin FQ receptor knockout mice;Mabrouk;Neuroscience,2010

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the binding interactions of NOP receptor with designed natural phytochemical-neuropeptide conjugates: an in silico and SPR study;Applied Biological Chemistry;2024-03-09

2. Comprehensive overview of biased pharmacology at the opioid receptors: biased ligands and bias factors;RSC Medicinal Chemistry;2021

3. Potential of Nociceptin/Orphanin FQ Peptide Analogs for Drug Development;Chemistry & Biodiversity;2020-12-22

4. Discovery and Structure–Activity Relationships of Nociceptin Receptor Partial Agonists That Afford Symptom Ablation in Parkinson’s Disease Models;Journal of Medicinal Chemistry;2020-01-17

5. Managing Parkinson's disease: moving ON with NOP;British Journal of Pharmacology;2020-01